Federal Register Notice: CDER is announcing the continuation of the Regulatory Project Management Site Tours and Regulatory Interaction Program and is inviting pharmaceutical companies interested in participating in this program to contact CDER. Companies may submit proposed agendas to the agency by 12/17. To view this notice, click here.
